Astec Lifesciences Stock Screener | Share Price & Fundamental Analysis
ASTEC
Pesticides & Agrochemicals
Share Price NSE
₹538.75
▼
-6.45 (-1.18%)
Share Price BSE
₹541.90
▼
-3.00 (-0.55%)
Track Astec Lifesciences share price live with TickJournal's free stock screener.
Analyze Astec Lifesciences share price history trends and compare 52-week high low
levels.
Record your trades in TickJournal's free trading journal and track your portfolio performance.
Astec Lifesciences Market Cap
₹1,209.93 Cr.
ASTEC P/E Ratio (TTM)
-13.92
Astec Lifesciences P/B Ratio
3.00
EPS (TTM)
₹-68.71
Dividend Yield
-
Debt to Equity
1.74
ASTEC 52 Week High
₹964.40
Astec Lifesciences 52 Week Low
₹521.85
Operating Margin
5.00%
Profit Margin
-13.33%
ASTEC Revenue (TTM)
₹120.00
EBITDA
₹6.00
Net Income
₹-16.00
Total Assets
₹881.00
Total Equity
₹235.00
Astec Lifesciences Share Price History - Stock Screener Chart
Screen ASTEC historical share price movements with interactive charts. Analyze price trends and patterns.
Astec Lifesciences Company Profile - Fundamental Screener
Screen Astec Lifesciences company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for ASTEC shares.
Sector
Chemicals
Industry
Pesticides & Agrochemicals
Sub-Sector
Pesticides & Agrochemicals
Segment
E
ISIN
INE563J01010
Astec Lifesciences Balance Sheet Screener
Screen ASTEC balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 881 | 975 | 979 | 897 | 678 | 572 | 461 | 413 | 334 | 330 |
| Current Assets | 341 | 399 | 499 | 516 | 330 | 332 | 249 | 232 | 198 | 191 |
| Fixed Assets | 499 | 386 | 319 | 340 | 213 | 194 | 167 | 115 | 103 | 95 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 281 | 208 | 34 | 10 | 46 | 7 | 10 | 5 | 2 | 9 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 235 | 370 | 420 | 397 | 309 | 247 | 203 | 170 | 138 | 118 |
| Share Capital | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 |
| Reserves & Surplus | 215 | 350 | 400 | 377 | 290 | 227 | 183 | 150 | 119 | 99 |
Astec Lifesciences Income Statement Screener - Profit & Revenue Analysis
Screen Astec Lifesciences income statement and profit fundamentals.
Analyze ASTEC quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Astec Lifesciences share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 120 | 92 | 75 | 126 | 156 | 70 | 101 | 96 | 130 | 145 | 112 | 52 | 279 | 187 | 204 |
| Expenses | 114 | 102 | 80 | 123 | 141 | 116 | 118 | 100 | 122 | 140 | 114 | 69 | 207 | 159 | 167 |
| EBITDA | 6 | -11 | -6 | 3 | 15 | -45 | -18 | -4 | 8 | 5 | -2 | -17 | 72 | 28 | 37 |
| Operating Profit % | 5.00% | -12.00% | -9.00% | 2.00% | 8.00% | -67.00% | -20.00% | -6.00% | 4.00% | 2.00% | -3.00% | -36.00% | 24.00% | 14.00% | 17.00% |
| Depreciation | 12 | 12 | 10 | 11 | 9 | 9 | 12 | 11 | 8 | 9 | 9 | 9 | 11 | 9 | 8 |
| Interest | 10 | 11 | 8 | 7 | 7 | 7 | 9 | 10 | 6 | 7 | 6 | 6 | 3 | 4 | 5 |
| Profit Before Tax | -16 | -33 | -24 | -16 | -1 | -62 | -39 | -25 | -6 | -11 | -18 | -32 | 58 | 15 | 25 |
| Tax | 0 | 0 | 0 | 0 | 0 | -22 | 0 | 15 | -1 | -3 | -4 | -8 | 15 | 4 | 6 |
| Net Profit | -16 | -33 | -24 | -16 | -1 | -40 | -39 | -40 | -5 | -8 | -13 | -24 | 43 | 11 | 18 |
| EPS | -8.20 | -16.85 | -11.35 | -7.04 | -0.50 | -20.26 | -19.66 | -20.59 | -2.54 | -4.18 | -6.85 | -12.41 | 21.97 | 5.82 | 9.34 |
Astec Lifesciences Cash Flow Screener - Liquidity Fundamentals
Screen ASTEC cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -8 | 10 | 75 | 24 | -8 | 168 | 15 | 65 | 19 | -13 |
| Investing Activities | -15 | -135 | -113 | -104 | -73 | -74 | -53 | -49 | -18 | -17 |
| Financing Activities | 24 | 125 | 38 | 81 | 81 | -95 | 37 | -18 | -1 | 31 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3 | 1 | 2 |
Astec Lifesciences Shareholding Pattern Screener
See Astec Lifesciences shareholding pattern with promoter, FII, and DII holdings.
Check Astec Lifesciences promoter holding and ownership changes for ASTEC on TickJournal.
| Item | 2025-Dec | 2025-Sept | 2025-Jul | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 71.97% | 72.42% | 72.42% | 70.87% | 70.87% | 66.75% | 66.75% | 66.75% |
| FII Holding | 0.04% | 0.00% | 0.02% | 0.02% | 0.25% | 1.20% | 0.53% | 1.03% |
| DII Holding | 3.17% | 4.01% | 4.01% | 4.26% | 4.34% | 5.41% | 4.51% | 3.38% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 20.87% | 19.32% | 18.96% | 19.98% | 19.62% | 20.71% | 21.95% | 22.52% |
| Other Holding | 3.95% | 4.25% | 4.59% | 4.87% | 4.91% | 5.93% | 6.26% | 6.33% |
| Shareholder Count | 22,293 | 18,276 | 18,889 | 18,549 | 18,689 | 19,057 | 19,727 | 19,955 |
Astec Lifesciences Share Dividend Screener - Share Yield Analysis
Check Astec Lifesciences dividend history with payout and yield data.
View Astec Lifesciences dividend details including ex-dates and amounts for ASTEC stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹1.50 | 0.14% |
| 2022-March | ₹1.50 | 0.11% |
| 2021-March | ₹1.50 | 0.09% |
| 2020-March | ₹1.50 | 0.15% |
| 2019-March | ₹1.50 | 0.39% |
| 2018-March | ₹1.50 | 0.28% |
| 2017-March | ₹1.50 | 0.26% |
Astec Lifesciences Stock Index Membership
See which indices include Astec Lifesciences stock.
Check ASTEC index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX CARBON
BSE INDEX SMLCAP
Astec Lifesciences Market Events Screener - Corporate Actions
Get Astec Lifesciences corporate actions including splits, bonuses, and buybacks.
Check Astec Lifesciences stock events that may affect ASTEC share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-01-30 | 2026-01-30 | Quarterly Result Announcement | NA | -12.93% |
| 2025-10-29 | 2025-10-29 | Quarterly Result Announcement | NA | -8.59% |
| 2025-07-28 | 2025-07-28 | Annual General Meeting | NA | 18.90% |
| 2025-07-28 | 2025-07-28 | Quarterly Result Announcement | NA | 0.28% |
| 2025-07-04 | 2025-07-04 | Rights | 1:7 | 1.17% |
| 2025-04-23 | 2025-04-23 | Quarterly Result Announcement | NA | 8.19% |
| 2025-01-27 | 2025-01-27 | Quarterly Result Announcement | NA | -5.28% |
| 2024-10-25 | 2024-10-25 | Quarterly Result Announcement | NA | -2.20% |
| 2024-07-29 | 2024-07-29 | Annual General Meeting | NA | -0.11% |
| 2023-07-27 | 2023-07-27 | Annual General Meeting | NA | -6.19% |
| 2023-07-21 | 2023-07-22 | Dividend | ₹ 1.50 /share | -2.96% |
| 2022-07-19 | 2022-07-21 | Dividend | ₹ 1.50 /share | 13.10% |
| 2021-07-22 | 2021-07-24 | Dividend | ₹ 1.50 /share | 19.13% |
Astec Lifesciences Competitors Screener - Peer Comparison
Screen ASTEC competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| UPL | 50,059 | 25.03 | 47,123 | 8.13% | 820 | 40.17 |
| PI Industries | 42,439 | 29.75 | 8,322 | 5.70% | 1,660 | 40.86 |
| Bayer Crop Science | 21,392 | 31.72 | 5,593 | 7.89% | 568 | 59.19 |
| Sumitomo Chemical | 19,132 | 35.70 | 3,269 | 11.19% | 506 | 46.24 |
| Sharda Cropchem | 8,005 | 14.18 | 4,379 | 35.89% | 304 | 35.71 |
| Rallis | 4,568 | 31.33 | 2,631 | 6.54% | 164 | 42.84 |
| Dhanuka Agritech | 4,341 | 14.32 | 2,071 | 15.49% | 297 | 45.18 |
| NACL Industries | 3,233 | -68.74 | 1,243 | -30.48% | -92 | 55.61 |
| Bhagiradha Chemicals & Industries | 2,558 | 190.98 | 450 | 9.63% | 14 | 52.32 |
| Bharat Rasayan | 2,344 | 16.34 | 1,199 | 12.53% | 141 | 50.54 |
Astec Lifesciences Company Announcements - News Screener
Screen ASTEC latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-04-01 | Closure of Trading Window | - |
| 2026-04-01 | Payment Of Interest On Non-Convertible Debentures | - |
| 2026-03-29 | Announcement under Regulation 30 (LODR)-Credit Rating | - |
| 2026-03-09 | Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations) - Disinvestment Of Equity Shares Held In Clean Max Andes Private Limited | - |
| 2026-02-24 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | - |
| 2026-02-06 | Reply On Significant Increase In The Volume Of Security | - |
| 2026-02-06 | Clarification sought from Astec Lifesciences Ltd | - |
| 2026-01-31 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-01-30 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-01-30 | Appointment Of Chief Financial Officer | - |
| 2026-01-30 | Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO) | - |
| 2026-01-30 | Outcome Of Board Meeting | - |
| 2026-01-30 | Board Meeting Outcome for Outcome Of Board Meeting | - |
| 2026-01-20 | Board Meeting Intimation for Board Meeting Intimation For Approving The Standalone And Consolidated Unaudited Financial Results For The Quarter And Nine Months Period Ended 31St December 2025 After These Results Are Reviewed By The Audit Committee. | - |
| 2026-01-13 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-12-24 | Closure of Trading Window | - |
| 2025-12-15 | Intimation Of Appointment Of Senior Management Personnel | - |
| 2025-11-07 | Disclosure Of Voting Results Of Postal Ballot Pursuant To Regulation 44 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2025-11-07 | Announcement under Regulation 30 (LODR)-Change in Directorate | - |
| 2025-11-07 | Disclosure Pursuant To Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |